Ana Alvarez, MD
Nizar F. Maraqa, MD, FPIDS
Entesar Husain, MD
In this series on Pediatric TB, the Pediatric ID Board Certifying Examination Content is presented by expert speakers via case-based, interactive webinars. The series goes beyond basic content while following the pediatric ID guidelines and is intended for a diverse audience, including pediatric infectious disease fellows and clinicians who diagnose and treat TB in children.
Target Audience: The course is designated for physicians, nurses, pharmacists, and field staff who interact with pediatric patients.
- Mycobacteriology, Pathogenesis, and Epidemiology
- Latent TB Infection
- Diagnosis - Old and New Tools & Challenges
As a result of participation in this activity, participants should be able to:
- Understand the general principles of antimicrobial use in TB medications for infants and children, including pharmacokinetic principles of absorption, distribution, metabolism, half-life, clearance, elimination and monitoring for toxicity/efficacy
- Identify high priority groups of infants and children who should be tested and treated for LTBI and active TB disease and interpret results of tests for same
- Recognize the clinical and radiographic manifestations of pulmonary and extrapulmonary TB in infants and children, including lymphadenitis, meningitis & miliary TB
Note: You must register for the training with the Southeastern National TB Center prior to taking the course. There are several trainings in this series: TB-285a, TB-285b, TB-285c.
Keywords: TB, tuberculosis, TB disease, MTB, Mycobacterium tuberculosis, MTB complex, LTBI. latent TB infection, pediatric, children